Is high-dose leuprorelin acetate effective and safe in asian men with prostate cancer? An open-label, non-comparative, multi-center clinical trial.
about
Extended release, 6-month formulations of leuprolide acetate for the treatment of advanced prostate cancer: achieving testosterone levels below 20 ng/dl.A semi-mechanistic integrated pharmacokinetic/pharmacodynamic model of the testosterone effects of the gonadotropin-releasing hormone agonist leuprolide in prostate cancer patients.
P2860
Is high-dose leuprorelin acetate effective and safe in asian men with prostate cancer? An open-label, non-comparative, multi-center clinical trial.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Is high-dose leuprorelin aceta ...... , multi-center clinical trial.
@en
Is high-dose leuprorelin aceta ...... , multi-center clinical trial.
@nl
type
label
Is high-dose leuprorelin aceta ...... , multi-center clinical trial.
@en
Is high-dose leuprorelin aceta ...... , multi-center clinical trial.
@nl
prefLabel
Is high-dose leuprorelin aceta ...... , multi-center clinical trial.
@en
Is high-dose leuprorelin aceta ...... , multi-center clinical trial.
@nl
P2093
P2860
P1476
Is high-dose leuprorelin aceta ...... , multi-center clinical trial.
@en
P2093
Choung-Soo Kim
Eun-Sik Lee
Hyun-Moo Lee
Sae-Woong Kim
Seung-Hwan Lee
Taek-Won Kang
P2860
P304
P356
10.3349/YMJ.2014.55.2.310
P577
2014-03-01T00:00:00Z